BioAlberta Member Feature story on PulseMedica, an edmonton-based medical device startup.

PulseMedica aims to transform vitreoretinal disease outcomes in the blink of an eye.

PulseMedica has raised an oversubscribed $2.6-million seed round, which it largely plans to use to run its first clinical trial beginning in June. The University of Alberta spinoff company is working on a new way to treat patients with major eye diseases.

How do you make the shift from deep tech research to commercializing a medical device? Finding the right team and partners, and focusing on the next milestone.

Alberta Innovates supports companies like PulseMedica as they develop technology to make our lives better.

The OIS podcast features leaders and drivers of ophthalmic innovation from around the world. In January 2022, PulseMedica’s CEO Nir Katchinskiy and Advisor Lahav Gil joined Dr. Ehsan Sadri MD FACS on the Ophthalmology Innovation Source (OIS) podcast.

PulseMedica Raises $12 Million CAD to Advance Eye Floater Imaging and Treatment Technology

Early-stage financing for Canadian startup developing ultrafast laser treatment of several eye diseases.

A company that’s working on a revolutionary solution for patients suffering from major eye diseases took home the top prize in the Edmonton third of Startup TNT’s Investment Summit IV.